Dr. Hannah Marie Barney, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1057 Red Ventures Dr Ste 150, Fort Mill, SC 29707 Phone: 704-375-0100 Fax: 704-887-6450 |
Clifford Netzler, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 704 Gold Hill Rd, Suite 115, Fort Mill, SC 29715 Phone: 803-802-5181 |
Karl Weber, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1935 Holbrook Rd, Ste 1200, Fort Mill, SC 29715 Phone: 803-802-5181 |
Dr. David B Stuver, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 502 Sixth Baxter Xing, Fort Mill, SC 29708 Phone: 803-396-8100 Fax: 803-396-8040 |
Olga V. Decker, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1935 Holbrook Rd, Ste 1200, Fort Mill, SC 29715 Phone: 803-802-5181 |
Shilpesh Shantilal Patel, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 515 River Crossing Dr, Suite 200, Fort Mill, SC 29715 Phone: 803-835-6500 Fax: 803-835-1990 |
Kashiti Genikka Nicole Long, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1935 Holbrook Rd, Ste 1200, Fort Mill, SC 29715 Phone: 803-802-5181 |
Surbhi Jain, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 704 Gold Hill Rd, Suite 115, Fort Mill, SC 29715 Phone: 803-802-5181 |
News Archive
New research which suggests a direct link between smoking and brain damage will be published in the July issue of the Journal of Neurochemistry. Researchers, led by Debapriya Ghosh and Dr Anirban Basu from the Indian National Brain Research Center (NBRC), have found that a compound in tobacco provokes white blood cells in the central nervous system to attack healthy cells, leading to severe neurological damage.
A new study shows for the first time that monkeys can recall and reproduce simple shapes from memory. Identifying this recall ability is critical to our understanding of the evolution of memory and other cognitive abilities, and it could be applied to better diagnosing and treating memory impairments in humans.
Akela Pharma, Inc., a leader in the development of therapeutics for the treatment of pain, and the company's wholly owned subsidiary, PharmaForm, today announced its financial results for the three and six months ended June 30, 2010.
Optivia Biotechnology Inc., a leading provider of in vitro transporter assay services, today announced that the company and the University of California, San Francisco (UCSF), have received a Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH) to develop an innovative system for characterizing the role transporter proteins play in the disposition of drugs by the liver.
In the last 15 years the U.S has seen a sharp increase in the number of babies born as late-preterm infants, between 34 and 37 weeks' gestation. This is approximately 400,000 children each year, comprising over 70 percent of all preterm births. Often, late-preterm infants are treated the same as full-term infants since they are commonly a similar size and weight. Growing research is showing that this can be detrimental to a late-preterm infant's health and frequently results in readmission to the hospital within the first month of life.
› Verified 2 days ago